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Maximum blink interval is 
associated with tear film breakup 
time: A new simple, screening test 
for dry eye disease
Takenori Inomata  1,2, Masao Iwagami3, Yoshimune Hiratsuka1, Keiichi Fujimoto1, 
Yuichi Okumura1, Tina Shiang4 & Akira Murakami  1
The prevalence of dry eye disease (DED) is increasing worldwide, and its diagnosis often needs dedicated 
reagents and machines. We investigated the usefulness of maximum blink interval (MBI) (the length of 
time that participants could keep their eyes open) in screening for DED. This cross-sectional study included 
292 patients (194 with DED and 98 without DED) recruited between September 2016 and September 
2017. We compared the MBI between patients with and without DED; examined correlations between 
MBI and other clinical features of DED, including subjective symptoms (Dry Eye-Related Quality-of-Life 
Score), tear film breakup time (TFBUT), cornea fluorescence score (CFS), and Schirmer test I value; and 
determined the optimal cutoff value of MBI to suspect DED using a receiver operating characteristic (ROC) 
analysis. The MBI was significantly shortened in DED group compared to the non-DED group (10.0 ± 9.1 
vs. 24.3 ± 38.2 seconds, p < 0.001). TFBUT was strongly positively correlated with MBI (r = 0.464), 
whereas CFS was negatively correlated with MBI (r = −0.273). The area under the ROC curve was 0.677, 
and the optimal MBI cutoff value was 12.4 seconds, providing a sensitivity of 82.5% and specificity of 
51.0% to suspect DED. In conclusion, MBI may be a simple, useful test for screening DED.
Dry eye disease (DED), a disorder of the tear film due to tear deficiency or excessive tear evaporation, damages the 
interpalpebral ocular surface and is associated with symptoms of ocular discomfort1. DED is diagnosed by triaging 
questions; risk factor analysis; diagnostic tests, such as questionnaire, non-invasive tear film breakup time (TFBUT), 
osmolality measurements and ocular surface staining2. Subsequently, subtype classification is performed using the 
Schirmer test and meibomian gland examination2. The prevalence of DED is currently estimated to be between 5 to 
50% and will increase due to aging society3, environmental factors4, stressful social environments5, and increased 
digital device usage4. Since it is thought that there are many people with undiagnosed DED who have a decreased 
quality of life (and quality of vision)6,7 and work productivity4, it is important to develop a simple self-screening tool 
for DED that can trigger a consultation between a patient and an ophthalmologist. The clinical assessment of DED 
needs dedicated reagents and machines, these assessments tools are not suitable for self-screening.
Blinking is an essential function of the eye that helps to spread tears, mucin, and lipids on the cornea and 
conjunctiva, which maintain the eye’s moisture and protect the eye from irritants8–10. There are three types of 
blinking: voluntary blinking is a brief lid closure that is intended to maintain the visual activity; periodic blinking 
occurs continuously and unconsciously during the awake time; and reflex blinking occurs as a reflex to protect 
the eye11. Periodic blinking rate can be affected by various factors, such as fatigue, eye injury, medication, diseases, 
and dryness10,12,13.
Blink rates, interblink interval (IBI), and maximum blink interval (MBI) have been demonstrated to be useful 
in distinguishing between normal participants and patients with DED14–17 because the local ocular conditions 
has been shown to affect the pattern of blinking17,18. Currently, the instability of the tear film is considered to be 
one of the core mechanisms of DED19,20. Therefore, it has been hypothesized that measurement of MBI, which is a 
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number of seconds the eyes can stay open without blinking17, can be simple a method to assess for DED. However, 
there have been few studies to assess the usefulness of MBI in the assessment of DED and to study the relationship 
between MBI and other clinical features of DED15,17,21.
In this study, we aimed to assess the usefulness of MBI in screening for DED by (i) comparing MBI between 
non-DED and DED patients, (ii) examining correlations between MBI and other test results for DED assessment, 
and (iii) conducting a receiver operating characteristic (ROC) analysis to identify the optimal MBI cutoff value to 
suspect DED. In addition, we assessed the blink interval period (BIP), which is the difference between MBI and 
TFBUT, to explore the mechanism of MBI.
Results
Participants’ characteristics. We enrolled 292 participants in this study. Table 1 shows the patients’ char-
acteristics. All participants underwent complete examination and were eligible for analysis. The average age was 
62.3 ± 14.9 years, and 82.2% of the participants were women. Based on the Asia Dry Eye Society (ADES) diag-
nostic criteria19, 98 participants were diagnosed as non-DED (33.6%), whereas 194 participants were diagnosed 
to have DED (66.4%). Positive subjective symptom rates, the Dry Eye-Related Quality-of-Life Score (DEQS)22, 
and corneal fluorescein staining (CFS) scores were significantly higher in the DED patients than in the non-DED 
participants. TFBUT was significantly lower in the DED patients than in the non-DED participants. The Schirmer 
test value was not significantly different between the groups.
Maximum blink interval (MBI) and blink induction period (BIP) between non-DED and DED. 
MBI and BIP were compared between the non-DED and DED groups (Table 1). MBI was significantly shorter in 
the DED group than in the non-DED group (9.5 ± 6.5 vs. 14.4 ± 8.9 seconds, p < 0.001). BIP was also significantly 
shorter in the DED group than in non-DED group (8.4 ± 9.0 vs. 11.2 ± 7.7 seconds, p < 0.001).
Correlations between MBI and other clinical assessment findings in DED. We examined the rela-
tionship between MBI and other clinical assessment findings in DED (DEQS, TFBUT, CFS and Schirmer test Ι) 
using the Pearson correlation test (Table 2). MBI was strongly correlated positively with TFBUT (r = 0.464) and 
negatively correlated with CFS (r = −0.273).
The cutoff value of MBI for detecting DED. Figure 1 shows the ROC curve illustrating the balance 
between sensitivity and specificity of different values of MBI in suspecting DED. The area under the ROC curve 
(AUC) was 0.677 (95%CI: 0.610–0.744). The optimum MBI cutoff value was 12.4 seconds, providing the sensitiv-
ity of 82.5% and the specificity of 51.0%.
The precision rate and characteristics of participants detected by MBI at the cutoff value of 
12.4 seconds. Table 3 shows the precision rate under the cutoff MBI value of 12.4 seconds. The positive pre-
dictive value was 76.9% (160/208), and the negative predictive value was 59.5% (50/84). Table 4 shows the char-
acteristics of participants divided into groups based on the MBI cutoff value of 12.4 second. Positive subjective 
symptoms rate, DEQS, TFBUT, CFS, and BIP were significantly worse in the less-than-12.4-seconds MBI group 
compared to more-than-12.4-seconds MBI group.
Classification Characteristics
Non-DED  
n = 98
DED  
n = 194 P value
Total  
N = 292
Age, y ± SD 65.6 ± 15.2 60.6 ± 14.6 0.007 62.3 ± 14.9
Female, n (%) 71 (72.4) 169 (87.1) 0.002 240 (82.2)
BCVA, LogMAR ± SD 0.0 ± 0.2 0.0 ± 0.2 0.043 0.0 ± 0.2
IOP, mmHg ± SD 13.2 ± 2.4 14.0 ± 2.8 0.028 13.7 ± 2.7
Subjective symptom, yes (%) 15 (15.3) 194 (100.0) <0.001 209 (71.6)
DEQS, 0–100 ± SD 11.6 ± 13.5 36.1 ± 22.4 <0.001 27.8 ± 23.0
TFBUT, sec ± SD 3.2 ± 3.4 1.6 ± 1.0 <0.001 2.1 ± 2.3
CFS score, 0–9 ± SD 2.4 ± 2.0 3.4 ± 2.3 <0.001 3.1 ± 2.3
Schirmer Ι, mm ± SD 6.0 ± 5.5 5.2 ± 6.2 0.280 5.5 ± 6.0
MBI, sec ± SD 14.4 ± 8.9 9.5 ± 6.5 <0.001 11.1 ± 7.7
BIP, sec ± SD 11.2 ± 7.7 8.4 ± 9.0 <0.001 9.0 ± 8.9
Table 1. The characteristics of study participants. P values were estimated using the t test for continuous 
variables and χ2 test for categorical variables. DED; dry eye disease, BCVA; best-corrected visual acuity, IOP; 
intraocular pressure, DEQS; the Dry Eye-Related Quality-of-Life Score, TFBUT; tear film breakup time, CFS; 
corneal fluorescein staining, MBI; maximum blink interval, BIP; blink induction period.
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Discussion
The new diagnostic criteria for DED have been recommended by ADES, and the diagnosis of DED can be made 
by subjective symptoms and decreased TFBUT (tear film instability)19. In this study, we showed the usefulness 
of MBI measurement as a simple DED screening method. The evaluation of tear film stability is important in the 
diagnosis of DED1,19, MBI measurement can be useful for many people if it can substitute for the measurement 
of TFBUT.
Our study demonstrated that MBI is strongly correlated with TFBUT (r = 0.464), indicating that tear breakup 
stresses the corneal surface, stimulates the underlying nociceptors, and induces blinking. Although MBI is 
thought to be associated with subjective symptoms, our correlation analysis showed that there was no significant 
correlation between MBI and subjective symptoms (DEQS), suggesting that MBI is independent from subjective 
symptoms and reflects the influence of TFBUT. Since the ADES diagnostic criteria are based on TFBUT and 
subjective symptoms, we concluded that MBI is suitable for the new ADES diagnostic criteria because MBI was 
associated with TFBUT in this study (Table 2).
Our study demonstrated that MBI was significantly shortened in DED patients compared to non-DED 
patients, which has also been observed in previous studies16,17. We have also suggested the optimal cutoff value 
of MBI (12.4 seconds) for detecting DED according to the ADES criteria. As shown in Table 3, using a cutoff of 
12.4 seconds of MBI for DED screening, the positive predictive value was 76.9% and the positive likelihood ratio 
was 1.68, indicating that MBI could accurately detect patients with DED. On the other hand, since ADES criteria 
excluded keratoconjunctival epithelial disorder and Schirmer test for the DED diagnosis19, MBI may not be suit-
able to evaluate keratoconjunctival epithelial disorder and tear-deficient DED, indicating that MBI should not be 
used to judge the severity or classification of DED.
Clinical items MBI DEQS TFBUT CFS Schirmer test I
MBI 1.000
DEQS *−0.168 1.000
TFBUT *0.464 −0.106 1.000
CFS *−0.273 0.015 *−0.298 1.000
Schirmer test I 0.105 0.028 *0.188 *−0.215 1.000
Table 2. The correlations between maximum blink interval and other clinical findings in dry eye disease. 
Pearson correlation coefficients were estimated among MBI, DEQS, TFBUT, and Schirmer test Ι. MBI; 
maximum blink interval, DEQS; the Dry Eye-Related Quality-of-Life Score, TFBUT; tear film breakup time, 
CFS; corneal fluorescein staining. P values are considered statistically significant at *p < 0.05.
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Figure 1. The receiver operator characteristic (ROC) curve for the detection of dry eye disease (DED) using 
maximum blink interval (MBI). (A) Represents the ROC curve for the detection of non-DED or DED group 
classified by the Asia Dry Eye Society diagnostic criteria using maximum blink interval (MBI). The AUC 
is 0.677 (95% CI: 0.610–0.744). ROC; receiver operator characteristic curve, DED; dry eye disease, MBI; 
maximum blink interval, AUC; area under the ROC curve.
Precision rate Non-DED  DED Total
MBI > 12.4 seconds (%) 50 (51.0) 34 (17.5) 84 (28.8)
MBI ≤ 12.4 seconds (%) 48 (49.0) 160 (82.5) 208 (71.2)
Total 98 (100) 194 (100) 292 (100)
Table 3. The precision rate detected by maximum blink interval at the cutoff value of 12.4 seconds. MBI; 
maximum blink interval, DED; dry eye disease.
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A variety of assessments have been utilized in evaluating DED, including measurement of TFBUT, CFS, Rose 
Bengal staining, Schirmer test and osmolality measurement2; however, most of these assessments need dedicated 
reagents and machines. IBI, another evaluation item that is similar to MBI14, also decreases in patients with DED; 
however, self-measurement of IBI is difficult, and the routine blink rate has not been shown to be related to local 
corneal and conjunctival factors17. Since MBI is a noninvasive and simple test, it is useful for self-screening in 
people with undiagnosed DED, and it offers the opportunity for making an appropriate diagnosis and subsequent 
proper use of eye drops for DED, including the use of over-the-counter eye drops.
BIP represents the time between the timing of dark spots occurrence on the ocular surface to the blinking (Fig. 1). 
This study showed that the BIP was reduced in the DED group compared to the one in the non-DED group (Table 1), 
suggesting that the instability of the tear film layer in DED shortens not only the TFBUT but also the BIP. A previous 
study reported that the total area of the tear film breakup was increased in DED23, via the mechanism of the decreased 
BIP due to the stimulation of the underlying nociceptors17. Therefore, we proposed that the mechanism of reduced 
both TFBUT and BIP (=MBI) is an increase in the number of blinking in patients with DED. Since it is expected that 
BIP will decrease in the evaporative-type DED, it may be important to study the BIP depending on the type of DED.
This study has a few limitations. This study may have selection bias because it was conducted in a university hospital 
in Japan and there are more female participants likely due to the predominance of females affected by DED24. We did 
not exclude patients with systemic diseases and systemic treatments. In addition, we did not measure Rose Bengal stain 
scores, tear osmolality, meibomian gland dysfunction, and corneal sensations to classify the DED in all participants 
because we wanted to develop a simple screening test that does not require dedicated reagents and machines.
In summary, the results of this study suggest MBI is useful in screening for DED. Specifically, the MBI of 
12.4 seconds or shorter was found to suggest a diagnosis of DED based on the 2016 ADES criteria. MBI may be 
useful for people with undiagnosed DED, and it offers the opportunity for conducting more specific examina-
tions, such as TFBUT, by ophthalmologists.
Participants and Methods
Study design and participants. This cross-sectional observational study included 292 patients recruited 
between September 2016 to September 2017 at Juntendo University Hospital, Department of Ophthalmology, 
Tokyo, Japan. A requirement for a written informed consent was waived due to the retrospective observational 
nature of the study, and it was carried out using the opt-out method on our hospital website. The clinical study 
was approved by the Juntendo University Hospital, Independent Ethics Committee (approval numbers: 15–185 
and 17-088) and adhered to the tenets of the Declaration of Helsinki.
Exclusion criteria. We excluded patients with a history of eye lid disorder, ptosis, mental disease, Parkinson 
disease, and any other disease that affects blinking.
Dry eye disease diagnosis and classification. Both eyes in all patients underwent complete ophthalmic 
evaluation, including measurement of best-corrected visual acuity, intraocular pressure (IOP), and assessment 
of subjective symptoms using the DEQS questionnaire22. TFBUT, CFS for kerato-conjunctival vital staining and 
Schirmer test Ι for reflex tear production were assessed in both eyes. Since blinking is affected by the condition 
of both eyes via the corneal reflex18, the lower TFBUT and Schirmer test Ι value data were used, whereas higher 
values of CFS were used in this study. We diagnosed DED and non-DED using the 2016 ADES criteria19. The 2016 
criteria make a diagnosis of DED with two positive items, specifically positive subjective symptoms and decreased 
TFBUT (≤5 seconds). We diagnosed DED if either eye had a diagnosis of DED by the 2016 criteria.
Environmental conditions. Temperature and humidity of the examination room were controlled at 26 °C 
in the summer and 24 °C in the winter and 50% relative humidity, according to the Guideline for Design and 
Operation of Hospital HVAC Systems established by Healthcare Engineering Association of Japan Standard25.
Characteristics
MBI > 12.4  
n = 84 (28.8)
MBI ≤ 12.4  
n = 208 (71.2) P value
Age, y ± SD 63.3 ± 14.2 61.9 ± 15.2 0.480
Female, n (%) 62 (73.8) 178 (85.6) 0.017
BCVA, LogMAR ± SD 0.0 ± 0.1 0.0 ± 0.2 0.320
IOP, mmHg ± SD 14.2 ± 2.9 13.5 ± 2.6 0.058
Subjective symptom, yes (%) 46 (54.8) 163 (78.4) <0.001
DEQS, 0–100 ± SD 22.6 ± 21.3 30.1 ± 23.3 0.013
TFBUT, sec ± SD 3.6 ± 3.3 1.5 ± 1.3 <0.001
CFS score, 0–9 ± SD 2.1 ± 1.9 3.5 ± 2.3 <0.001
Schirmer Ι, mm ± SD 6.4 ± 6.6 5.1 ± 5.6 0.080
BIP, sec ± SD 17.6 ± 6.9 5.5 ± 2.6 <0.001
Table 4. The characteristics of participants detected by maximum blink interval at the cutoff value of 
12.4 seconds. P values were determined using the t test for continuous variables and χ2 test for categorical 
variables. MBI; maximum blink interval, BCVA; best-corrected visual acuity, IOP; intraocular pressure, DEQS; 
the Dry Eye-Related Quality-of-Life Score, TFBUT; tear film breakup time, CFS; corneal fluorescein staining, 
BIP; blink interval period.
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Subjective symptoms and Dry Eye-Related Quality-of-Life Score (DEQS). Subjective symptoms 
were assessed by interviewing participants with DED. The DEQS questionnaire was administered to assess the 
severity of dry eye-associated symptoms and the multifaceted effects of DED on the patients’ daily lives22. The 
score derived from this questionnaire is a subjective measurement of DED symptoms where 0 indicates the best 
score (no symptoms) and 100 indicates the worst score (maximum symptoms).
Clinical assessments for DED. TFBUT and kerato-conjunctival vital staining (CFS) were assessed with 
fluorescein sodium (Fluores Ocular Examination Test Paper, Ayumi Pharmaceutical Co., Tokyo, Japan) staining. 
We performed TFBUT, CFS, MBI measurement, and Schirmer test I.
Tear film breakup time (TFBUT). TFBUT was measured using a fluorescein dye according to the standard 
method19. To minimize the effect of the test strip on tear volume and TFBUT, a small quantity of the dye was 
administered with a wetted fluorescein strip. After the dye was instilled, the subject was instructed to blink three 
times to ensure adequate mixing of the dye with the tears. The time interval between the last blink and the appear-
ance of the first dark spot on the cornea was measured with a stopwatch. The mean value of three measurements 
was used. The cutoff value of TFBUT ≤5 seconds was used to diagnose DED19.
Kerato-conjunctival vital staining (cornea fluorescence staining [CFS]). CFS was graded according 
to the van Bijsterveld grading system26, dividing the ocular surface into three zones: nasal bulbar conjunctiva, 
temporal bulbar conjunctiva, and cornea. Each zone was evaluated on a scale of 0 to 3, with 0 indicating no stain-
ing and 3 indicating confluent staining. The maximum possible score is 9.
Maximum blink interval (MBI) and blink induction period (BIP). The length of time that the partic-
ipants could keep the eye open before blinking during each trial was termed the MBI (Fig. 2). We measured the 
MBI twice by a stopwatch under a light microscope without light. MBI was recorded as 30 seconds if it exceeded 
30 seconds. BIP was calculated by subtracting TFBUT from MBI.
Schirmer test I. The Schirmer test I was performed without topical anesthesia after the completion of all 
other examinations. Schirmer test strips (Ayumi Pharmaceutical Co., Tokyo, Japan) were placed at the outer 
one-third of the temporal lower conjunctival fornix for 5 minutes. The strips were then removed, and the length 
of dampened filter paper (in mm) was recorded.
Statistical analyses. To compare the characteristics of study participants, the t test was used for continuous 
variables and χ2 test was used for categorical variables. Pearson correlation coefficients were estimated among 
MBI, DEQS, TFBUT, and Schirmer test Ι . A ROC analysis was conducted to examine the diagnostic efficacy of 
MBI for DED. The ROC curve was plotted by computing the sensitivity and specificity using each symmetric 
value of the rating variable as a possible cutoff point. A point was plotted on the graph for each of the cutoff 
points; these plotted points were joined by straight lines to form the ROC curve, and the AUC was estimated 
using the trapezoidal rule. To determine the optimal cutoff value of MBI for detecting DED, the point where sen-
sitivity and specificity were maximized was identified. Data are presented as means ± standard deviations (SDs) 
or proportions. Statistical analyses were performed using STATA version 14 (Stata Corp, Texas). A P < 0.05 was 
considered significant.
Figure 2. The definition of maximum blink interval (MBI) and blink induction period (BIP). (A) Show how 
to determine the tear film breakup time (TFBUT), MBI and BIP. TFBUT was the time interval between the 
last blink (A) and the appearance of the first dark spot on the cornea (B). MBI was the length of time that 
participants could keep the eye open before blinking (A–D). BIP was calculated by subtracting TFBUT from 
MBI (C,D). MBI; maximum blink interval, TFBUT; tear film breakup time, BIP; blink interval period.
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